Cargando…
Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579540/ https://www.ncbi.nlm.nih.gov/pubmed/36253637 http://dx.doi.org/10.1007/s11239-022-02707-4 |
| _version_ | 1784812204176965632 |
|---|---|
| author | Vazquez, Sara R. Wilson, Aaron S. Witt, Daniel M. |
| author_facet | Vazquez, Sara R. Wilson, Aaron S. Witt, Daniel M. |
| author_sort | Vazquez, Sara R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9579540 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95795402022-10-19 Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series Vazquez, Sara R. Wilson, Aaron S. Witt, Daniel M. J Thromb Thrombolysis Letter to the Editor Springer US 2022-10-18 2022 /pmc/articles/PMC9579540/ /pubmed/36253637 http://dx.doi.org/10.1007/s11239-022-02707-4 Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Vazquez, Sara R. Wilson, Aaron S. Witt, Daniel M. Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series |
| title | Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series |
| title_full | Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series |
| title_fullStr | Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series |
| title_full_unstemmed | Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series |
| title_short | Management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series |
| title_sort | management of potential drug-drug interactions with nirmatrelvir-ritonavir and oral anticoagulants: a case series |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9579540/ https://www.ncbi.nlm.nih.gov/pubmed/36253637 http://dx.doi.org/10.1007/s11239-022-02707-4 |
| work_keys_str_mv | AT vazquezsarar managementofpotentialdrugdruginteractionswithnirmatrelvirritonavirandoralanticoagulantsacaseseries AT wilsonaarons managementofpotentialdrugdruginteractionswithnirmatrelvirritonavirandoralanticoagulantsacaseseries AT wittdanielm managementofpotentialdrugdruginteractionswithnirmatrelvirritonavirandoralanticoagulantsacaseseries |